Literature DB >> 8822958

Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine.

S T Ong, H Koeppen, R A Larson, O I Olopade.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8822958

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

Review 1.  Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.

Authors:  J C Adkins; D H Peters; A Markham
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

2.  Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide.

Authors:  Masaki Yamaguchi; Takeharu Kotani; Yoshihisa Nakamura; Mikio Ueda
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

3.  Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Authors:  Nathalie Mourad; Nicolas Mounier; Josette Brière; Emmanuel Raffoux; Alain Delmer; Alfred Feller; Chris J L M Meijer; Jean-François Emile; Réda Bouabdallah; André Bosly; Jacques Diebold; Corinne Haioun; Bertrand Coiffier; Christian Gisselbrecht; Philippe Gaulard
Journal:  Blood       Date:  2008-02-21       Impact factor: 22.113
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.